



@article {3272,
	title = {Cellular strategies to promote vascularisation in tissue engineering applications},
	journal = {European Cells and Materials},
	volume = {28},
	year = {2014},
	note = {Export Date: 21 November 2014},
	month = {2014},
	pages = {51 - 67},
	abstract = {Vascularisation is considered to be one of the greatest challenges in tissue engineering. Different strategies exist but cell-based approaches have emerged as a promising therapy to achieve successful vascularisation. The use of endothelial cells to engineer vascularised tissues has been extensively investigated. This field of research has evolved with the discovery of endothelial progenitor cells, a subpopulation with a high regenerative potential. However, the survival of endothelial cell populations alone seems to be impaired. To overcome this problem, co-culture systems, involving supporting cells, like mural cells, fibroblasts, or more tissue-specific cells have been developed. Endothelial cells benefit from the extracellular matrix components and growth factors produced by the supporting cells, which results in neovessel stabilisation and maturation. The use of endothelial progenitor cells in co-culture systems appears to be a promising strategy to promote vascularisation in approaches of increasing complexity. Herein, the authors provide an overview of the cellular strategies that can be used for increasing vascularisation in tissue engineering and regeneration.},
	keywords = {angiogenesis, Cellular therapies, Co-culture models, Endothelial progenitor cells, Regeneration},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84904957526\&partnerID=40\&md5=dbd4f3056e55c7dc52bc526ea7eb7d69},
	author = {Costa-Almeida, R. and Granja, P.L. and Soares, R. and Guerreiro, S.G.}
}
@article {3266,
	title = {Injectable alginate hydrogels for cell delivery in tissue engineering},
	journal = {Acta Biomaterialia},
	volume = {10},
	year = {2014},
	note = {Export Date: 21 November 2014},
	month = {2014},
	pages = {1646 - 1662},
	abstract = {Alginate hydrogels are extremely versatile and adaptable biomaterials, with great potential for use in biomedical applications. Their extracellular matrix-like features have been key factors for their choice as vehicles for cell delivery strategies aimed at tissue regeneration. A variety of strategies to decorate them with biofunctional moieties and to modulate their biophysical properties have been developed recently, which further allow their tailoring to the desired application. Additionally, their potential use as injectable materials offers several advantages over preformed scaffold-based approaches, namely: Easy incorporation of therapeutic agents, such as cells, under mild conditions; minimally invasive local delivery; and high contourability, which is essential for filling in irregular defects. Alginate hydrogels have already been explored as cell delivery systems to enhance regeneration in different tissues and organs. Here, the in vitro and in vivo potential of injectable alginate hydrogels to deliver cells in a targeted fashion is reviewed. In each example, the selected crosslinking approach, the cell type, the target tissue and the main findings of the study are highlighted. {\textcopyright} 2013 Acta Materialia Inc.},
	keywords = {Alginate, Cell delivery, Injectable, Regeneration, Tissue engineering},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-84896403229\&partnerID=40\&md5=fd56573baeefa91edfc45ba61cf0573a},
	author = {Bidarra, S.J. and Barrias, C.C. and Granja, P.L.}
}
@article {2239,
	title = {Non-viral gene delivery to mesenchymal stem cells: Methods, strategies and application in bone tissue engineering and regeneration},
	journal = {Current Gene TherapyCurr. Gene Ther.},
	volume = {11},
	year = {2011},
	note = {Cited By (since 1996): 8Export Date: 21 November 2012Source: ScopusCODEN: CGTUAdoi: 10.2174/156652311794520102PubMed ID: 21182464Language of Original Document: EnglishCorrespondence Address: Tom{\'a}s, H.; CQM-Centro de Qu{\'\i}mica da Madeira, MMRG, Universidade da Madeira, Campus Universit{\'a}rio da Penteada, 9000-390 Funchal, Portugal; email: lenat@uma.ptReferences: Bianco, P., Robey, P.G., Simmons, P.J., Mesenchymal stem cells: Revisitinghistory, concepts, and assays (2008) Cell Stem Cell, 2, pp. 313-319;Marot, D., Knezevic, M., Novakovic, G.V., Bone tissue engineeringwith human stem cells (2010) Stem Cell Res Ther, 1, p. 10; 
Caplan, A.I., Review: Mesenchymal stem cells: Cell-based reconstructivetherapy in orthopedics (2005) Tissue Eng, 11, pp. 1198-1211; 
Caplan, A.I., Bruder, S.P., Mesenchymal stem cells: Building blocksfor molecular medicine in the 21st century (2001) Trends Mol Med, 7, pp. 259-264; 
Chen, F.H., Tuan, R.S., Mesenchymal stem cells in arthritic diseases (2008) Arthritis Res Ther, 10, p. 223; 
Da Silva Meirelles, L., Chagastelles, P.C., Nardi, N.B., Mesenchymalstem cells reside in virtually all post-natal organs and tissues (2006) J CellSci, 119, pp. 2204-2213; 
Mauney, J.R., Volloch, V., Kaplan, D.L., Role of adult mesenchymalstem cells in bone tissue engineering applications: Current statusand future prospects (2005) Tissue Eng, 11, pp. 787-802; 
Prockop, D.J., Repair of tissues by adult stem/progenitor cells(MSCs): Controversies, myths, and changing paradigms (2009) Mol Ther, 17, pp. 939-946; 
Sakurada, K., McDonald, F.M., Shimada, F., Regenerative medicineand stem cell based drug discovery (2008) Angew Chem Int Ed Engl, 47, pp. 5718-5738; 
V{\"a}{\"a}n{\"a}nen, H.K., Mesenchymal stem cells (2005) Ann Med, 37, pp. 469-479; 
Jackson, W.M., Nesti, L.J., Tuan, R.S., Potential therapeutic applicationsof muscle-derived mesenchymal stem and progenitor cells (2010) ExpertOpin Biol Ther, 10, pp. 505-517; 
Nauta, A.J., Fibbe, W.E., Immunomodulatory properties of mesenchymalstromal cells (2007) Blood, 110, pp. 3499-3506; 
Heyde, M., Partridge, K.A., Oreffo, R.O., Gene therapy used fortissue engineering applications (2007) J Pharm Pharmacol, 59, pp. 329-350; 
Kimelman, N., Pelled, G., Helm, G.A., Review: Gene-and stemcell-based therapeutics for bone regeneration and repair (2007) TissueEng, 13, pp. 1135-1150; 
Partridge, K.A., Oreffo, R.O., Gene delivery in bone tissue engineering: Progress and prospects using viral and nonviral strategies (2004) TissueEng, 10, pp. 295-307; 
Pittenger, M., Vanguri, P., Simonetti, D., Adult mesenchymalstem cells: Potential for muscle and tendon regeneration and use ingene therapy (2002) J Musculoskelet Neuronal Interact, 2, pp. 309-320; 
Reiser, J., Zhang, X.Y., Hemenway, C.S., Potential of mesenchymalstem cells in gene therapy approaches for inherited and acquireddiseases (2005) Expert Opin Biol Ther, 5, pp. 1571-1584; 
Saraf, A., Mikos, A.G., Gene delivery strategies for cartilage tissueengineering (2006) Adv Drug Deliv Rev, 58, pp. 592-603; 
Trippel, S.B., Ghivizzani, S.C., Nixon, A.J., Gene-based approaches forthe repair of articular cartilage (2004) Gene Ther, 11, pp. 351-359; 
Takahashi, K., Yamanaka, S., Induction of pluripotent stem cells frommouse embryonic and adult fibroblast cultures by defined factors (2006) Cell, 126, pp. 663-676; 
Yu, J., Vodyanik, M.A., Smuga-Otto, K., Induced pluripotentstem cell lines derived from human somatic cells (2007) Science, 318, pp. 1917-1920; 
Steinert, A.F., Noth, U., Tuan, R.S., Concepts in gene therapy for cartilagerepair (2008) Injury, 39 (SUPPL 1), pp. S97-S113; 
Gafni, Y., Turgeman, G., Liebergal, M., Stem cells as vehiclesfor orthopedic gene therapy (2004) Gene Ther, 11, pp. 417-426; 
Kane, N.M., McRae, S., Denning, C., Viral and non-viral genedelivery and its role in pluripotent stem cell engineering Drug DiscovToday: Technol, , In press. doi:10.1016/j.ddtec.2008.10.002; 
Li, S.D., Huang, L., Non-viral is superior to viral gene delivery (2007) JControl Release, 123, pp. 181-183; 
Mastrobattista, E., Bravo, S.A., van der Aa, M., Nonviral genedelivery systems: From simple transfection agents to artificial viruses (2005) Drug Discov Today: Technol, 2, pp. 103-109; 
Chan, J., O{\textquoteright}Donoghue, K., de la Fuente, J., Human fetal mesenchymalstem cells as vehicles for gene delivery (2005) Stem Cells, 23, pp. 93-102; 
Tsuda, H., Wada, T., Yamashita, T., Enhanced osteoinduction bymesenchymal stem cells transfected with a fiber-mutant adenoviralBMP2 gene (2005) J Gene Med, 7, pp. 1322-1334; 
Zhang, X., Godbey, W.T., Viral vectors for gene delivery in tissueengineering (2006) Adv Drug Deliv Rev, 58, pp. 515-534; 
Dang, J.M., Leong, K.W., Natural polymers for gene delivery and tissue engineering (2006) Adv Drug Deliv Rev, 58, pp. 487-499; 
Luten, J., van Nostrum, C.F., De Smedt, S.C., Biodegradablepolymers as non-viral carriers for plasmid DNA delivery (2008) J ControlRelease, 126, pp. 97-110; 
Mintzer, M.A., Simanek, E.E., Nonviral vectors for gene delivery (2009) Chem Rev, 109, pp. 259-302; 
Panyam, J., Labhasetwar, V., Biodegradable nanoparticles for drugand gene delivery to cells and tissue (2003) Adv Drug Deliv Rev, 55, pp. 329-347; 
Choi, J.S., Ko, K.S., Park, J.S., Dexamethasone conjugatedpoly(amidoamine) dendrimer as a gene carrier for efficient nucleartranslocation (2006) Int J Pharm, 320, pp. 171-178; 
Roth, C.M., Sundaram, S., Engineering synthetic vectors for improvedDNA delivery: Insights from intracellular pathways (2004) Annu RevBiomed Eng, 6, pp. 397-426; 
Wood, K.C., Little, S.R., Langer, R., A family of hierarchicallyself-assembling linear-dendritic hybrid polymers for highly efficienttargeted gene delivery (2005) Angew Chem Int Ed Engl, 44, pp. 6704-6708; 
Mehier-Humbert, S., Guy, R.H., Physical methods for gene transfer: Improving the kinetics of gene delivery into cells (2005) Adv Drug DelivRev, 57, pp. 733-753; 
Jo, J., Tabata, Y., Non-viral gene transfection technologies for geneticengineering of stem cells (2008) Eur J Pharm Biopharm, 68, pp. 90-104; 
Song, L., Chau, L., Sakamoto, Y., Electric field-induced molecularvibration for noninvasive, high-efficiency DNA transfection (2004) Mol Ther, 9, pp. 607-616; 
Han, S.W., Nakamura, C., Kotobuki, N., High-efficiency DNAinjection into a single human mesenchymal stem cell using ananoneedle and atomic force microscopy (2008) Nanomedicine, 4, pp. 215-225; 
Park, S., Kim, Y.S., Kim, W.B., Carbon nanosyringe array as aplatform for intracellular delivery (2009) Nano Lett, 9, pp. 1325-1329; 
Durieux, A.C., Bonnefoy, R., Busso, T., In vivo gene electrotransferinto skeletal muscle: Effects of plasmid DNA on the occurrenceand extent of muscle damage (2004) J Gene Med, 6, pp. 809-816; 
Winn, S.R., Hu, Y., Sfeir, C., Gene therapy approaches for modulatingbone regeneration (2000) Adv Drug Deliv Rev, 42, pp. 121-138; 
Lv, H., Zhang, S., Wang, B., Toxicity of cationic lipids and cationicpolymers in gene delivery (2006) J Control Release, 114, pp. 100-109; 
Gebhart, C.L., Kabanov, A.V., Evaluation of polyplexes as gene transferagents (2001) J Control Release, 73, pp. 401-416; 
Hamm, A., Krott, N., Breibach, I., Efficient transfection methodfor primary cells (2002) Tissue Eng, 8, pp. 235-245; 
Gill, D.R., Pringle, I.A., Hyde, S.C., Progress and prospects: The designand production of plasmid vectors (2009) Gene Ther, 16, pp. 165-171; 
Miller, A.M., Dean, D.A., Tissue-specific and transcription factormediatednuclear entry of DNA (2009) Adv Drug Deliv Rev, 61, pp. 603-613; 
Smith, D.K., Dendrimers and the double helix--from DNA bindingtowards gene therapy (2008) Curr Top Med Chem, 8, pp. 1187-1203; 
Duzgunes, N., De Ilarduya, C.T., Simoes, S., Cationic liposomesfor gene delivery: Novel cationic lipids and enhancement by proteinsand peptides (2003) Curr Med Chem, 10, pp. 1213-1220; 
Hoekstra, D., Rejman, J., Wasungu, L., Gene delivery by cationiclipids: In and out of an endosome (2007) Biochem Soc Trans, 35, pp. 68-71; 
Hoelters, J., Ciccarella, M., Drechsel, M., Nonviral genetic modificationmediates effective transgene expression and functionalRNA interference in human mesenchymal stem cells (2005) J Gene Med, 7, pp. 718-728; 
Ko, B.S., Chang, T.C., Shyue, S.K., An efficient transfectionmethod for mouse embryonic stem cells (2009) Gene Ther, 16, pp. 154-158; 
Park, J., Lutz, R., Felszeghy, E., The effect on bone regenerationof a liposomal vector to deliver BMP-2 gene to bone grafts in periimplantbone defects (2007) Biomaterials, 28, pp. 2772-2782; 
Park, J., Ries, J., Gelse, K., Bone regeneration in critical sizedefects by cell-mediated BMP-2 gene transfer: A comparison of adenoviral vectors and liposomes (2003) Gene Ther, 10, pp. 1089-1098; 
Vanderbyl, S., McDonald, G.N., Sidhu, S., Transfer and stabletransgene expression of a mammalian artificial chromosome intobone marrow-derived human mesenchymal stem cells (2004) Stem Cells, 22, pp. 324-333; 
de Jong, G., Telenius, A., Vanderbyl, S., Efficient in-vitro transferof a 60-Mb mammalian artificial chromosome into murine and hamster cells using cationic lipids and dendrimers (2001) ChromosomeRes, 9, pp. 475-485; 
Dass, C.R., Cytotoxicity issues pertinent to lipoplex-mediated genetherapy in-vivo (2002) J Pharm Pharmacol, 54, pp. 593-601; 
Wu, G.Y.W.C., Receptor-mediated in vitro gene transformation by asoluble DNA carrier system (1987) J Biol Chem, 262, pp. 4429-4432; 
Choi, Y.H., Liu, F., Kim, J.S., Polyethylene glycol-grafted poly-Llysineas polymeric gene carrier (1998) J Control Release, 54, pp. 39-48; 
Liu, G., Molas, M., Grossmann, G.A., Biological properties of poly-L-lysine-DNA complexes generated by cooperative binding of the polycation (2001) J Biol Chem, 276, pp. 34379-34387; 
Farrell, L.L., Pepin, J., Kucharski, C., A comparison of the effectivenessof cationic polymers poly-L-lysine (PLL) and polyethylenimine(PEI) for non-viral delivery of plasmid DNA to bone marrowstromal cells (BMSC) (2007) Eur J Pharm Biopharm, 65, pp. 388-397; 
Incani, V., Tunis, E., Clements, B.A., Palmitic acid substitutionon cationic polymers for effective delivery of plasmid DNA tobone marrow stromal cells (2007) J Biomed Mater Res A, 81, pp. 493-504; 
Clements, B.A., Incani, V., Kucharski, C., A comparative evaluationof poly-L-lysine-palmitic acid and Lipofectamine 2000 forplasmid delivery to bone marrow stromal cells (2007) Biomaterials, 28, pp. 4693-4704; 
Bragonzi, A., Boletta, A., Biffi, A., Comparison between cationicpolymers and lipids in mediating systemic gene delivery to thelungs (1999) Gene Ther, 6, pp. 1995-2004; 
Sea, F., Exgen 500 is an efficient vector for gene delivery tolung epithelial cells in vitro and in vivo (1997) Gene Ther, 4, pp. 1100-1106; 
Wightman, L., Kircheis, R., Rossler, V., Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo (2001) J Gene Med, 3, pp. 362-372; 
Behr, J.-P., The Proton Sponge: A Trick to Enter Cells the VirusesDid Not Exploit (1997) Chimia, 51, pp. 34-36; 
Dea, F., A novel non-viral vector for DNA delivery based onlow molecular weight, branched polyethylenimine: Effect of molecularweight on transfection efficiency and cytotoxicity (1999) Pharm. Res, 16, pp. 1273-1279; 
Godbey, W.T., Wu, K.K., Mikos, A.G., Size matters: Molecular weightaffects the efficiency of poly(ethylenimine) as a gene delivery vehicle (1999) J Biomed Mater Res, 45, pp. 268-275; 
Ahn, H.H., Lee, M.S., Cho, M.H., DNA/PEI nano-particles forgene delivery of rat bone marrow stem cells (2008) Colloids and SurfacesA: Physicochem Eng Aspects, 313-314, pp. 116-120; 
Ahn, H.H., Lee, J.H., Kim, K.S., Polyethyleneimine-mediated genedelivery into human adipose derived stem cells (2008) Biomater, 29, pp. 2415-2422; 
Clements, B.A., Bai, J., Kucharski, C., RGD conjugation to polyethyleneiminedoes not improve DNA delivery to bone marrowstromal cells (2006) Biomacromolecules, 7, pp. 1481-1488; 
Saraf, A., Hacker, M.C., Sitharaman, B., Synthesis and conformationalevaluation of a novel gene delivery vector for human mesenchymalstem cells (2008) Biomacromolecules, 9, pp. 818-827; 
Lei, Y., Segura, T., DNA delivery from matrix metalloproteinasedegradable poly(ethylene glycol) hydrogels to mouse cloned mesenchymalstem cells (2009) Biomaterials, 30, pp. 254-265; 
Gwak, S.J., Kim, B.S., Poly(lactic-co-glycolic acid) nanosphere as avehicle for gene delivery to human cord blood-derived mesenchymalstem cells: Comparison with polyethylenimine (2008) Biotechnol Lett, 30, pp. 1177-1182; 
Yang, F., Green, J.J., Dinio, T., Gene delivery to human adult and embryonic cell-derived stem cells using biodegradable nanoparticulatepolymeric vectors (2009) Gene Ther, 16, pp. 533-546; 
Huang, M., Fong, C.W., Khor, E., Transfection efficiency of chitosan vectors: Effect of polymer molecular weight and degree of deacetylation (2005) J Control Release, 106, pp. 391-406; 
Ishii, T., Okahata, Y., Sato, T., Mechanism of cell transfection withplasmid/chitosan complexes (2001) Biochim Biophys Acta, 1514, pp. 51-64; 
Moreira, C., Oliveira, H., Pires, L.R., Improving chitosanmediatedgene transfer by the introduction of intracellular bufferingmoieties into the chitosan backbone (2009) Acta Biomater, 5, pp. 2995-3006; 
Sato, T., Ishii, T., Okahata, Y., In vitro gene delivery mediated bychitosan. effect of pH, serum, and molecular mass of chitosan onthe transfection efficiency (2001) Biomaterials, 22, pp. 2075-2080; 
Corsi, K., Chellat, F., Yahia, L., Mesenchymal stem cells, MG63and HEK293 transfection using chitosan-DNA nanoparticles (2003) Biomaterials, 24, pp. 1255-1264; 
Nie, H., Wang, C.H., Fabrication and characterization of PLGA/HApcomposite scaffolds for delivery of BMP-2 plasmid DNA (2007) J ControlRelease, 120, pp. 111-121; 
Hu, Y., Cai, K., Luo, Z., Surface mediated in situ differentiationof mesenchymal stem cells on gene-functionalized titanium filmsfabricated by layer-by-layer technique (2009) Biomaterials, 30, pp. 3626-3635; 
Okazaki, A., Jo, J., Tabata, Y., A reverse transfection technology togenetically engineer adult stem cells (2007) Tissue Eng, 13, pp. 245-251; 
Hosseinkhani, H., Azzam, T., Kobayashi, H., Combination of 3Dtissue engineered scaffold and non-viral gene carrier enhance in vitroDNA expression of mesenchymal stem cells (2006) Biomaterials, 27, pp. 4269-4278; 
Hosseinkhani, H., Yamamoto, M., Inatsugu, Y., Enhanced ectopicbone formation using a combination of plasmid DNA impregnationinto 3-D scaffold and bioreactor perfusion culture (2006) Biomaterials, 27, pp. 1387-1398; 
Duf{\`e}s, C., Uchegbu, I.F., Sch{\"a}tzlein, A.G., Dendrimers in gene delivery (2005) Adv Drug Deliv Rev, 57, pp. 2177-2202; 
Svenson, S., Tomalia, D.A., Dendrimers in biomedical applications--reflections on the field (2005) Adv Drug Deliv Rev, 57, pp. 2106-2129; 
Malik, N., Wiwattanapatapee, R., Klopsch, R., Dendrimers: Relationshipbetween structure and biocompatibility in vitro, and preliminarystudies on the biodistribution of 125I-labelled polyamidoaminedendrimers in vivo (2000) J Control Release, 65, pp. 133-148; 
Duncan, R., Izzo, L., Dendrimer biocompatibility and toxicity (2005) AdvDrug Deliv Rev, 57, pp. 2215-2237; 
Dennig, J., Duncan, E., Gene transfer into eukaryotic cells usingactivated polyamidoamine dendrimers (2002) J Biotechnol, 90, pp. 339-347; 
Sokolova, V.V., Radtke, I., Heumann, R., Effective transfection of cells with multi-shell calcium phosphate-DNA nanoparticles (2006) Biomaterials, 27, pp. 3147-3153; 
Santos, J.L., Oramas, E., Pego, A.P., Osteogenic differentiation of mesenchymal stem cells using PAMAM dendrimers as gene deliveryvectors (2009) J Control Release, 134, pp. 141-148; 
Gheisari, Y., Soleimani, M., Azadmanesh, K., Multipotent mesenchymalstromal cells: Optimization and comparison of five cationicpolymer-based gene delivery methods (2008) Cytotherapy, 10, pp. 815-823; 
Holladay, C., Keeney, M., Greiser, U., A matrix reservoir forimproved control of non-viral gene delivery (2009) J Control Release, 136, pp. 220-225; 
Parekh, H.S., The advance of dendrimers-a versatile targeting platformfor gene/drug delivery (2007) Curr Pharm Des, 13, pp. 2837-2850; 
Santos, J.L., Pandita, D., Rodrigues, J., Receptor-mediated genedelivery using PAMAM dendrimers conjudated with peptides recognizedby mesenchymal stem cells (2010) Mol Pharmaceutics, 7, pp. 763-774; 
Santos, J.L., Oliveira, H., Pandita, D., Rodrigues, J., Functionalizationof Poly(amidoamine) Dendrimers with hydrophobic chains forimproved gene delivery in mesenchymal stem cells (2010) J Control Release, 144, pp. 55-64; 
Bourgeat-Lami, E., Organic-inorganic nanostructured colloids (2002) JNanosci Nanotechnol, 2, pp. 1-24; 
Chowdhury, E.H., Akaike, T., Bio-functional inorganic materials: Anattractive branch of gene-based nano-medicine delivery for 21stcentury (2005) Curr Gene Ther, 5, pp. 669-676; 
Sokolova, V., Epple, M., Inorganic nanoparticles as carriers of nucleicacids into cells (2008) Angew Chem Int Ed Engl, 47, pp. 1382-1395; 
Uchimura, E., Yamada, S., Uebersax, L., Method for reversetransfection using gold colloid as a nano-scaffold (2007) J Biosci Bioeng, 103, pp. 101-103; 
Gonzalez-McQuire, R., Green, D.W., Partridge, K.A., Coating of human mesenchymal cells in 3D culture with bioinorganicnanoparticles promotes osteoblastic differentiation and gene transfection (2007) Adv Mater, 19, pp. 2236-2240; 
Park, J.S., Na, K., Woo, D.G., Non-viral gene delivery of DNApolyplexed with nanoparticles transfected into human mesenchymalstem cells (2010) Biomaterials, 31, pp. 124-132; 
Peister, A., Mellad, J.A., Wang, M., Stable transfection of MSCsby electroporation (2004) Gene Ther, 11, pp. 224-228; 
Ferreira, E., Potier, E., Logeart-Avramoglou, D., Optimization of a gene electrotransfer method for mesenchymal stem cell transfection (2008) Gene Ther, 15, pp. 537-544; 
Ziv, R., Steinhardt, Y., Pelled, G., Micro-electroporation of mesenchymalstem cells with alternating electrical current pulses (2009) BiomedMicrodevices, 11, pp. 95-101; 
Lim, J.Y., Park, S.H., Jeong, C.H., Microporation is a valuabletransfection method for efficient gene delivery into human umbilicalcord blood-derived mesenchymal stem cells (2010) BMC Biotechnol, 10, p. 38; 
Lee, S.-J., Kang, S.-W., Do, H.-J., Enhancement of bone regenerationby gene delivery of BMP2/Runx2 bicistronic vector into adipose-derived stromal cells (2010) Biomater, 31, pp. 5652-5659; 
Lakshmipathy, U., Pelacho, B., Sudo, K., Efficient transfection of embryonic and adult stem cells (2004) Stem Cells, 22, pp. 531-543; 
Aluigi, M., Fogli, M., Curti, A., Nucleofection is an efficientnonviral transfection technique for human bone marrow-derivedmesenchymal stem cells (2006) Stem Cells, 24, pp. 454-461; 
Nakashima, S., Matsuyama, Y., Nitta, A., Highly efficient transfectionof human marrow stromal cells by nucleofection (2005) TransplantProc, 37, pp. 2290-2292; 
Miller, D.L., Pislaru, S.V., Greenleaf, J.E., Sonoporation: MechanicalDNA delivery by ultrasonic cavitation (2002) Somat Cell Mol Genet, 27, pp. 115-134; 
Otani, K., Yamahara, K., Ohnishi, S., Nonviral delivery of siRNA into mesenchymal stem cells by a combination of ultrasoundand microbubbles (2009) J Control Release, 133, pp. 146-153; 
Aslan, H., Sheyn, D., Gazit, D., Genetically engineered mesenchymalstem cells: Applications in spine therapy (2009) Regen Med, 4, pp. 99-108; 
Chiang, G.G., Rubin, H.L., Cherington, V., Bone marrow stromalcell-mediated gene therapy for hemophilia A: In vitro expression of human factor VIII with high biological activity requires the inclusionof the proteolytic site at amino acid 1648 (1999) Hum Gene Ther, 10, pp. 61-76; 
Gelse, K., von der Mark, K., Schneider, H., Cartilage regeneration bygene therapy (2003) Curr Gene Ther, 3, pp. 305-317; 
Moutsatsos, I.K., Turgeman, G., Zhou, S., Exogenously regulatedstem cell-mediated gene therapy for bone regeneration (2001) Mol Ther, 3, pp. 449-461; 
Phillips, M.I., Tang, Y.L., Genetic modification of stem cells for transplantation (2008) Adv Drug Deliv Rev, 60, pp. 160-172; 
Schwarz, E.J., Reger, R.L., Alexander, G.M., Rat marrow stromalcells rapidly transduced with a self-inactivating retrovirus synthesizeL-DOPA in vitro (2001) Gene Ther, 8, pp. 1214-1223; 
Sun, M., Kong, L., Wang, X., Coexpression of tyrosine hydroxylase, GTP cyclohydrolase I, aromatic amino acid decarboxylase, and vesicular monoamine transporter 2 from a helper virus-freeherpes simplex virus type 1 vector supports high-level, long-termbiochemical and behavioral correction of a rat model of Parkinson{\textquoteright}sdisease (2004) Hum Gene Ther, 15, pp. 1177-1196; 
Turgeman, G., Pittman, D.D., Muller, R., Engineered humanmesenchymal stem cells: A novel platform for skeletal cell mediatedgene therapy (2001) J Gene Med, 3, pp. 240-251; 
Tuszynski, M.H., Thal, L., Pay, M., A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease (2005) Nat Med, 11, pp. 551-555; 
Fang, J., Zhu, Y.Y., Smiley, E., Stimulation of new bone formationby direct transfer of osteogenic plasmid genes (1996) Proc Natl AcadSci U S A, 93, pp. 5753-5758; 
Bonadio, J., Smiley, E., Patil, P., Localized, direct plasmid genedelivery in vivo: Prolonged therapy results in reproducible tissueregeneration (1999) Nat Med, 5, pp. 753-759; 
Kasper, F.K., Young, S., Tanahashi, K., Evaluation of bone regenerationby DNA release from composites of oligo(poly(ethyleneglycol) fumarate) and cationized gelatin microspheres in a criticalsizedcalvarial defect (2006) J Biomed Mater Res A, 78, pp. 335-342; 
Kuroda, S., Kondo, H., Ohya, K., A new technique with calciumphosphate precipitate enhances efficiency of in vivo plasmid DNAgene transfer (2005) J Pharmacol Sci, 97, pp. 227-233; 
Endo, M., Kuroda, S., Kondo, H., Bone regeneration by modifiedgene-activated matrix: Effectiveness in segmental tibial defects inrats (2006) Tissue Eng, 12, pp. 489-497; 
Huang, Y.C., Simmons, C., Kaigler, D., Bone regeneration in a ratcranial defect with delivery of PEI-condensed plasmid DNA encodingfor bone morphogenetic protein-4 (BMP-4) (2005) Gene Ther, 12, pp. 418-426; 
Nie, H., Ho, M.L., Wang, C.K., BMP-2 plasmid loadedPLGA/HAp composite scaffolds for treatment of bone defects innude mice (2009) Biomaterials, 30, pp. 892-901; 
Ono, I., Yamashita, T., Jin, H.Y., Combination of porous hydroxyapatiteand cationic liposomes as a vector for BMP-2 genetherapy (2004) Biomaterials, 25, pp. 4709-4718; 
Kishimoto, K.N., Watanabe, Y., Nakamura, H., Ectopic boneformation by electroporatic transfer of bone morphogenetic protein-4 gene (2002) Bone, 31, pp. 340-347; 
Sheyn, D., Kimelman-Bleich, N., Pelled, G., Ultrasound-basednonviral gene delivery induces bone formation in vivo (2008) Gene Ther, 15, pp. 257-266; 
Hosseinkhani, H., Inatsugu, Y., Hiraoka, Y., Impregnation of plasmid DNA into three-dimensional scaffolds and medium perfusionenhance in vitro DNA expression of mesenchymal stem cells (2005) Tissue Eng, 11, pp. 1459-1475; 
Hosseinkhani, H., Hosseinkhani, M., Gabrielson, N.P., DNAnanoparticles encapsulated in 3D tissue-engineered scaffolds enhanceosteogenic differentiation of mesenchymal stem cells (2007) JBiomed Mater Res A, 85, pp. 47-60; 
Huang, Y.C., Kaigler, D., Rice, K.G., Combined angiogenic and osteogenic factor delivery enhances bone marrow stromal celldrivenbone regeneration (2005) J Bone Miner Res, 20, pp. 848-857; 
Blum, J.S., Barry, M.A., Mikos, A.G., In vivo evaluation of genetherapy vectors in ex vivo-derived marrow stromal cells for boneregeneration in a rat critical-size calvarial defect model (2003) Hum GeneTher, 14, pp. 1689-1701; 
Aslan, H., Zilberman, Y., Arbeli, V., Nucleofection-based ex vivononviral gene delivery to human stem cells as a platform for tissueregeneration (2006) Tissue Eng, 12, pp. 877-889; 
Noel, D., Gazit, D., Bouquet, C., Short-term BMP-2 expression issufficient for in vivo osteochondral differentiation of mesenchymalstem cells (2004) Stem Cells, 22, pp. 74-85
},
	month = {2011///},
	pages = {46 - 57},
	abstract = {Mesenchymal stem cells (MSCs) can be isolated from several tissues in the body, have the ability to selfrenewal, show immune suppressive properties and are multipotent, being able to generate various cell types. At present, due to their intrinsic characteristics, MSCs are considered very promising in the area of tissue engineering and regenerative medicine. In this context, genetic modification can be a powerful tool to control the behavior and fate of these cells and be used in the design of new cellular therapies. Viral systems are very effective in the introduction of exogenous genes inside MSCs. However, the risks associated with their use are leading to an increasing search for non-viral approaches to attain the same purpose, even if MSCs have been shown to be more difficult to transfect in this way. In the past few years, progress was made in the development of chemical and physical methods for non-viral gene delivery. Herein, an overview of the application of those methods specifically to MSCs is given and their use in tissue engineering and regenerative medicine therapeutic strategies highlighted using the example of bone tissue. Key issues and future directions in non-viral gene delivery to MSCs are also critically addressed. {\textcopyright} 2011 Bentham Science Publishers Ltd.},
	keywords = {Animals, article, artificial chromosome, Bone and Bones, Bone Regeneration, bone tissue, Bone tissue engineering, cell based gene therapy, dendrimer, ex vivo gene transfer, Gene delivery, gene targeting, Gene therapy, Gene Transfer Techniques, gene vector, genetic transfection, human, Humans, in vivo gene transfer, liposome, Mesenchymal stem cell, Mesenchymal Stem Cells, nanomedicine, nanoparticle, Non-viral vectors, nonhuman, nonviral gene delivery system, polymer, protein expression, Regeneration, Regenerative Medicine, Tissue engineering, Tissue regeneration},
	isbn = {15665232 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-79951686783\&partnerID=40\&md5=c9cc095fac56b04808553b19fd1f5f48},
	author = {Santos, J.L. and Pandita, D. and Rodrigues, J. and P{\^e}go, A.P. and Granja, P.L. and Tom{\'a}s, H.}
}
@article {2364,
	title = {A clinical report of bone regeneration in maxillofacial surgery using bonelike{\textregistered} synthetic bone graft},
	journal = {Journal of Biomaterials ApplicationsJ. Biomater. Appl.},
	volume = {22},
	year = {2008},
	note = {Cited By (since 1996): 6Export Date: 21 November 2012Source: ScopusCODEN: JBAPEdoi: 10.1177/0885328207078260Language of Original Document: EnglishCorrespondence Address: Santos, J.D.; Instituto de Engenharia Biom{\'e}dica, Laborat{\'o}rio de Biomateriais, Rua Campo Alegre 823, 4150-180 Porto, Portugal; email: jdsantos@fe.up.ptChemicals/CAS: Bone SubstitutesReferences: Mohamed, A., Sudha, K., Kim, F., Karl, K., Scott, P.B., Bone Graft Substitutes (2003) Cell Based Approaches for Bone Graft Substitutes, p. 127. , In: Laurencin, C.T. (ed.), Chapter 7 ASTM - International, USA;Mellonig, J.T., Prewett, A.B., Moyer, M.P., HIV Inactivation in a Bone Allograft (1992) J. Periodontol., 63, p. 979; 
Buck, B.E., Malinin, T.I., Brown, M.D., Bone Transplantation and Human Immunodeficiency Virus. An Estimate of Risk of Acquired Immunodeficiency Syndrome (AIDS) (1989) Clin. Orthop., 240, p. 129; 
Mary, E.A.R., Raymond, A.Y., Bone Replacement Grafts - The Bone Substitutes (1998) Dent. Clin. North Am., 42 (3), p. 491; 
Doron, I.I., Amy, L.L., Bone Graft Substitutes (2002) Oper. Tech. Plast. Reconsr. Surg., 9 (4), p. 151; 
Wright, S., Commentary The Bone-Graft Market in Europe, in Emerging Technologies in Orthopedics I: Bone Graft Substitutes (1999) Bone Growth Stimulators and Bone Growth Factors By Datamonitor Plc, p. 591; 
Knaack, D., Goad, M.E.P., Aiolova, M., Christian, R., Ali, T., Promod, C., Duke Lee, D., Resorbable Calcium Phosphate Bone Substitute (1998) J. Biomed. Mater. Res., 43, p. 399; 
Frayssinet, P., Trouillet, J.L., Rouquet, N., Azimus, E., Autefage, A., Osseointegration Macroporous Calcium Phosphate Ceramics Having a Different Chemical Composition (1993) Biomaterials, 14, p. 423; 
Klein, C.P.A.T., Driessen, A.A., Groot de, K., van den Hooff, A., Biodegradation Behavior of Various Calcium Phosphate Materials in Bone Tissue (1983) J. Biomed. Mater. Res., 17, p. 769; 
Daculsi, G., Biphasic Calcium Phosphate Concept Applied to Artificial Bone, Implant Coating and Injectable Bone Substitute (1998) Biomaterials, 19, p. 1473; 
Santos, J.D., Hastings, G.W., Knowles, J.C., Sintered Hydroxyapatite Compositions and Method for the Preparation Thereof (1999) Worldwide Applications, , (PCT), Patent No. 1 189 851; 
Lopes, M.A., Santos, J.D., Monteiro, F.J., Knowles, J.C., Glass Reinforced Hydroxyapatite: A Comprehensive Study of the Effect of Glass Composition on the Crystallography of the Composite (1998) J. Biomed. Mater. Res., 39, p. 244; 
Lopes, M.A., Monteiro, F.J., Santos, J.D., Glass-reinforced Hydroxyapatite Composites: Fracture Toughness and Hardness Dependence on Microstructural Characteristics (1999) Biomaterials, 20, p. 2085; 
Lopes, M.A., Silva, R.F., Monteiro, F.J., Santos, J.D., Microstructural Dependence of Young{\textquoteright}s and Shear Moduli of P 2 O 2 Glass Reinforced Hydroxyapatite for Biomedical Applications (2000) Biomaterials, 21, p. 749; 
Lopes, M.A., Santos, J.D., Monteiro, F.J., Ohtsuki, C., Osaka, A., Kaneko, S., Inoue, H., Push-out Testing and Histological Evaluation of Glass Reinforced Hydroxyapatite Composites Implanted in the Tibia of Rabbits (2001) J. Biomed. Mater. Res., 54, p. 463; 
Lobato, J.V., Hussain, N.S., Botelho, C.M., Rodrigues, J.M., Lu{\'\i}s, A.L., Maur{\'\i}cio, A.C., Lopes, M.A., Santos, J.D., Assessment of the Potential of Bonelike{\textregistered} Graft for Bone Regeneration by using an Animal Model (2005) Key. Eng. Mater., 877, pp. 284-286; 
Lobato, J.V., Hussain, N.S., Botelho, C.M., Mauricio, A.C., Afonso, A., Ali, N., Santos, J.D., Assessment of Bonelike{\textregistered} Graft with a Resorbable Matrix using an Animal Model (2006) Thin Solid Films, 515, p. 362; 
Duarte, F., Santos, J.D., Afonso, A., Medical Applications of Bonelike{\textregistered} in Maxillofacial Surgery (2004) Mater. Sci. Forum, 370, pp. 455-456; 
Gutierres, M., Hussain, N.S., Afonso, A., Almeida, L., Cabral, T., Lopes, M.A., Santos, J.D., Biological Behaviour of Bonelike{\textregistered} Graft Implanted in Tibia of Humans (2005) Key Eng. Mater., 1041, pp. 284-286; 
LeGeros, R.Z., Properties of Osteoconductive Biomaterials: Calcium Phosphates (2002) Clin. Orthop., 395, p. 81; 
Robert, D.A.G., Hanneke, G.T., Ronald, J.H., Buma, P., Mechanism of Bone Incorporation of β-TCP Bone Substitute in Open Wedge Tibial Osteotomy in Patients (2005) Biomaterials, 26, p. 6713; 
Hirotsugu, H., Norio, A., Kimimitsu, O., Noritaka, F., Ohnishi, H., Okada, A., Nomura, S., Maeda, T., A Histological Evaluation on Self setting α-tricalcium Phosphate Applied in the Rat Bone Cavity (2004) Biomaterials, 25, p. 431; 
Meinel, L., Betz, O., Fajardo, R., Hofmann, S., Nazarian, A., Cory, E., Hilbe, M., Kirker-Head, C., Silk Based Biomaterials to Heal Critical Sized Femur Defects (2006) Bone, 39, p. 922; 
Lim, S.C., Lee, M.J., Yeo, H.H., Effects of Various Implant Materials on Regeneration of Calvarial Defects in Rats (2000) Pathol. Int., 50, p. 594; 
Carano, R.A.D., Filvaroff, E.H., Angiogenesis and Bone Repair (2003) Drug Discov. Today, 21, p. 980; 
Gutierres, M., Hussain, N.S., Lopes, M.A., Afonso, A., Cabral, A.T., Almeida, L., Santos, J.D., Histomorphometric Measurements Histological and SEM Analyses of bone/ implant Interface: Clinical Trials using Bonelike{\textregistered} Granules (2006) J. Orthop. Res., 24, p. 953
},
	month = {2008///},
	pages = {373 - 385},
	abstract = {The objective of this study is to evaluate the osteoconductivity and bioactivity of the Bonelike{\textregistered} graft in repairing surgical cystic bone defects. Bonelike{\textregistered} is implanted in 11 patients, aged between 24 and 53 years with a mean age of 36 years, consisting of 5 men and 6 women. According to the standard follow up protocols, radiological examinations are performed and Bonelike{\textregistered} /bone retrieved samples have been analyzed histologically using non-decalcified sections obtained perpendicular to bone length axis. Radiographic examination and histological results clearly demonstrate an extensive new bone formation apposed on Bonelike{\textregistered} granules with a significant degree of maturation. These clinical applications in maxillary bone defects indicate perfect bone bonding between new bone formed and Bonelike{\textregistered} granules, along with partial surface biodegradation. This quick and effective osteoconductive response from Bonelike{\textregistered} may reduce the time needed to reconstruct the bone defected area of patients. {\textcopyright} 2008 Sage Publications.},
	keywords = {adult, article, Bioactivity, Bone, bone prosthesis, Bone Regeneration, Bone Substitutes, bone transplantation, Bonelike{\textregistered}, clinical trial, facial bone, Facial Bones, Female, Histological studies, histology, human, Humans, Implants (surgical), instrumentation, male, Maxillofacial surgery, methodology, Middle Aged, oral surgery, Pathology, Radiography, Radiology, Regeneration, Surgery, Surgery, Oral, Synthetic bone graft, treatment outcome},
	isbn = {08853282 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-37249042186\&partnerID=40\&md5=ab2c9e9614d3f4f521445c149cff57ec},
	author = {Sousa, R.C. and Lobato, J.V. and Maur{\'\i}cio, A.C. and Hussain, N.S. and Botelho, C.M. and Lopes, M.A. and Santos, J.D.}
}
@article {2452,
	title = {Mineralization of regenerated cellulose hydrogels induced by human bone marrow stromal cells},
	journal = {European Cells and MaterialsEur. Cells and Mater.},
	volume = {10},
	year = {2005},
	note = {Cited By (since 1996): 7Export Date: 21 November 2012Source: ScopusPubMed ID: 16217723Language of Original Document: EnglishCorrespondence Address: Granja, P.L.; INEB - Instituto de Engenharia Biom{\'e}dica, Laborat{\'o}rio de Biomateriais, Rua do Campo Alegre, 823, 4150-180 Porto, Portugal; email: pgranja@ineb.up.ptChemicals/CAS: cellulose, 61991-22-8, 68073-05-2, 9004-34-6; hydroxyapatite, 1306-06-5, 51198-94-8; Calcium Phosphates; Cellulose, 9004-34-6; Hydrogels; calcium phosphate, 10103-46-5References: (1994) Evaluation Biologique des Dispositifs M{\'e}dicaux. Partie 5: Essais Concernant la Cytotoxicit{\'e}: M{\'e}thodes in Vitro. (Biological Evaluation of Medical Devices. Part 5: Cytotoxicity Assays: in Vitro Methods), , www.afnor.fr, AFNOR-NF EN 30993-5. Association Fran{\c c}aise de Normalization, Saint-Denis la Plaine, France;Albrektsson, T., Hard tissue response (1998) Handbook Of Biomaterial Properties, pp. 500-512. , Black J, Hastings G (eds). Chapman \& Hall, London; 
Am{\'e}d{\'e}e, J., Bareille, R., Jeandot, R., Bordenave, L., Remy, M., Rouais, F., Baquey, C., Evaluation of cell colonization on biomaterials: Preventing cell attachment to plastic containers (1994) Biomaterials, 15, pp. 1029-1031; 
Bergsma, J.E., De Bruijn, W.C., Rozema, F.R., Bos, R.R.M., Boering, G., Late degradation tissue response to poly(L-lactide) bone plates and screws (1995) Biomaterials, 16, pp. 25-31; 
Bohic, S., Heymann, D., Pouezat, J.A., Gauthier, O., Daculsi, G., Transmission FT-IR microspectroscopy of mineral phases in calcified tissues (1998) Sciences de la Vie, 321, pp. 865-876; 
Burgess, E.A., Hollinger, J.O., Options for engineering bone (1998) Frontiers in Tissue Engineering, pp. 383-399. , Patrick Jr CW, Mikos AG, McIntire LV (eds). Elsevier Science, Oxford; 
Chauveaux, D., Barbie, C., Barthe, X., Baquey, C., Poustis, J., Biological behaviour of cellulosic materials after bone implantation: Preliminary results (1990) Clin Mater, 5, pp. 251-258; 
Choee, J.H., Lee, S.J., Lee, Y.M., Rhee, J.M., Lee, H.B., Khang, G., Proliferation rate of fibroblast cells on polyethylene surfaces with wettability gradient (2004) J Appl Polym Sci, 92, pp. 599-606; 
Curtis, A.S.G., Forrester, J.V., Clark, P., Substrate hydroxylation and cell adhesion (1986) J Cell Sci, 86, pp. 9-24; 
Dasarathy, H., Riley, C., Coble, H.D., Analysis of apatite deposits on substrates (1993) J Biomed Mater Res, 27, pp. 477-482; 
Degenshein, G.A., Hurwitz, A., Ribacoff, S., Experience with regenerated oxidized cellulose (1963) NY State J Med, 63, pp. 2639-2643; 
Dias, G.J., Peplow, P.V., Teixeira, F., Osseous regeneration in the presence of oxidized cellulose and collagen (2003) J Mater Sci Mater Med, 14, pp. 739-745; 
Dumitriu, S., Dumitriu, M., Hydrogels as support for drug delivery systems (1996) Polysaccharides in Medicinal Applications, pp. 705-764. , Dumitriu S (ed.). Marcel Dekker, New York; 
Franz, G., Polysaccharides in pharmacy (1986) Adv Polym Sci, 76, pp. 1-30; 
Friedman, R.J., Black, J., Galante, J.O., Jacobs, J.J., Skinner, H.B., Current concepts in orthopaedic biomaterials and implant fixation (1993) J Bone Joint Surg, 75 A, pp. 1086-1109; 
Galgut, P.N., Oxidized cellulose mesh. I. Biodegradable membrane in periodontal surgery (1990) Biomaterials, 11, pp. 561-564; 
Granja, P.L., Pouys{\'e}gu, L., Deffieux, D., Daud{\'e}, G., De J{\'e}so, B., Labrug{\`e}re, C., Baquey, C., Barbosa, M.A., Cellulose phosphates as biomaterials. Surface chemical modification of regenerated cellulose hydrogels (2001) J Appl Polym Sci, 82, pp. 3354-3365; 
Granja, P.L., Pouys{\'e}gu, L., De J{\'e}so, B., Rouais, F., Baquey, C., Barbosa, M.A., Cellulose phosphates as biomaterials. Mineralization of chemically modified regenerated cellulose hydrogels (2001) J Mater Sci, 36, pp. 2163-2172; 
Granja, P.L., Ribeiro, C.C., De J{\'e}so, B., Baquey, C., Barbosa, M.A., Mineralization of regenerated cellulose hydrogels (2001) J Mater Sci: Mater Med, 12, pp. 785-791; 
Hayashi, T., Biodegradable polymers for biomedical uses (1994) Prog Polym Sci, 19, pp. 663-702; 
Healy, K.E., Thomas, C.H., Rezania, A., Kim, J.E., McKeown, P.J., Lom, B., Hockberger, P.E., Kinetics of bone cell organization and mineralization on materials with patterned surface chemistry (1996) Biomaterials, 17, pp. 195-208; 
Hon, D.N.-S., Cellulose and its derivatives: Structures, reactions, and medical uses (1996) Polysaccharides in Medicinal Applications, pp. 87-105. , Dumitriu D (ed.). Marcel Dekker, New York; 
Horbett, T.A., The role of adsorbed proteins in tissue response to biomaterials (2004) Biomaterials Science: An Introduction to Materials in Medicine, 2nd Ed., pp. 237-246. , Ratner BD, Hoffman AS, Schoen FJ, Lemons JE (eds.). Elsevier-Academic Press, San Diego; 
Hosseini, M.M., Sodek, J., Franke, R.-P., Davies, J.E., The structure and composition of the bone-implant interface (2000) Bone Engineering, pp. 295-304. , Davies JE (ed.). em squared inc., Toronto; 
Ikada, Y., Biomedical applications of cellulose membranes (1989) Cellulose: Structural and Functional Aspects, pp. 447-455. , Kennedy JF, Phillips GO, Williams PA (eds.). Ellis Horwood, Chichester; 
Ishaug, S.L., Crane, G.M., Miller, M.J., Yasko, A.W., Yaszemski, M.J., Mikos, A.G., Bone formation by three-dimensional stromal osteoblast culture in biodegradable polymer scaffolds (1997) J Biomed Mater Res, 36, pp. 17-28; 
(1992) Biological Evaluation of Medical Devices. Test for Cytotoxicity: in Vitro Methods, , www.iso.org, ISO 10993-5. International Organization for Standardization, Geneva, Switzerland; 
Lamba, N.M.K., Baumgartner, J.A., Cooper, S.L., Cell-synthetic surface interactions (1998) Frontiers in Tissue Engineering, pp. 121-137. , Patrick Jr CW, Mikos AG, McIntire LV (eds). Elsevier Science, Oxford; 
Lee, J.H., Lee, J.W., Khang, G., Lee, H.B., Interaction of cells on chargeable functional group gradient surfaces (1997) Biomaterials, 18, pp. 351-358; 
Martson, M., Viljanto, J., Hurme, T., Saukko, P., Biocompatibility of cellulose sponge with bone (1998) Eur Surg Res, 30, pp. 426-432; 
Martson, M., Viljanto, J., Hurme, T., Laippala, P., Saukko, P., Is cellulose sponge degradable or stable as implantation materials? An in vivo subcutaneous study in the rat (1999) Biomaterials, 20, pp. 1899-1995; 
McFarland, C.D., Mayer, S., Scotchford, C., Dalton, B.A., Steele, J.G., Downes, S., Attachment of cultured human bone cells to novel polymers (1999) J Biomed Mater Res, 44, pp. 1-11; 
Miyamoto, T., Takahashi, S., Ito, H., Inagaki, H., Noishiki, Y., Tissue biocompatibility of cellulose and its derivatives (1989) J Biomed Mater Res, 23, pp. 125-133; 
Mosmann, T., Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays (1983) J Immunol Meth, 65, pp. 55-63; 
Patrick Jr., C.W., Mikos, A.G., McIntire, L.V., Prospectus of tissue engineering (1998) Frontiers in Tissue Engineering, pp. 3-11. , Patrick Jr CW, Mikos AG, McIntire LV (eds). Elsevier Science, Oxford; 
Pommier, J.C., Poustis, J., Baquey, C., Chauveaux, D., (1990), Biocompatible, hydrophilic material. Method of manufacture and uses of same (Fr Pat 8610331, 1986; Eur Pat 0256906 A1, 1987) US Pat 4904258Poustis, J., Baquey, C., Chauveaux, D., Mechanical properties of cellulose in orthopaedic devices and related environments (1994) Clin Mater, 16, pp. 119-124; 
Puleo, D.A., Bizios, R., Formation of focal contacts by osteoblasts cultured on orthopedic biomaterials (1992) J Biomed Mater Res, 26, pp. 291-301; 
Puleo, D.A., Nanci, A., Understanding and controlling the bone-implant interface (1999) Biomaterials, 20, pp. 2311-2321; 
Shelton, R.M., Rasmussen, A.C., Davies, J.E., Protein adsorption at the interface between charged polymer substrata and migrating osteoblasts (1988) Biomaterials, 9, pp. 24-29; 
Skoog, T., The use of periosteum and surgicel{\textregistered} for bone restoration in congenital clefts of the maxilla (1967) Scand J Plast Reconstr Surg, 1, pp. 113-130; 
Smetana Jr., K., Cell biology of hydrogels (1993) Biomaterials, 14, pp. 1046-1050; 
Uysal, A., Ozbek, S., Ozcan, M., Comparison of the biological activities of high-density porous polyethylene implants and oxidized regenerated cellulose-wrapped diced cartilage grafts (2003) Plast Reconstr Surg, 112, pp. 540-546; 
Vert, M., Mauduit, J., Li, S., Biodegradation of PLA/GA polymers: Increasing complexity (1994) Biomaterials, 15, pp. 1209-1213; 
Vilamitjana-Am{\'e}d{\'e}e, J., Bareille, R., Rouais, F., Caplan, A.I., Harmand, M.F., Human bone marrow stromal cells express an osteoblastic phenotype in culture (1993) In Vitro Cell Dev Biol, 29 A, pp. 699-707; 
Recum, H.A., Yaszemski, M.J., Mikos, A.G., Tissue engineering concepts (1999) Handbook of Biomaterials Evaluation: Scientific, Technical and Clinical Testing of Implant Materials, 2nd Ed., pp. 385-409. , von Recum AF (ed.), Edwards Brothers, Ann Arbor; 
Webb, K., Hlady, V., Tresco, P.A., Relative importance of surface wettability and charged functional groups on NIH 2T3 fibroblast attachment, spreading and cytoskeletal organization (1998) J Biomed Mater Res, 41, pp. 422-430; 
Yaszemski, M.J., Payne, R.G., Hayes, W.C., Langer, R., Mikos, A.G., Evolution of bone transplantation: Molecular, cellular and tissue strategies to engineer human bone (1996) Biomaterials, 17, pp. 175-185; 
Kristen, H., Bosch, P., Bednar, H., Plenk Jr., H., Biocompatibility of wood in bone tissue (1977) Arch Orthop Unfallchir, 89, pp. 1-14; 
Kristen, H., Bosch, P., Bednar, H., Plenk Jr., H., The effects of dynamic loading on intracalcaneal wood implants and on the tissues surrounding them (1979) Arch Orthop Trauma Surg, 93, pp. 287-292; 
Li, S.H., Liu, Q., De Wijn, J., Zhou, B.L., De Groot, K., Calcium phosphate formation induced on silica in bamboo (1997) J Mater Sci Mater Med, 8, pp. 427-433; 
Li, S.H., Liu, Q., De Wijn, J.R., Zhou, B.L., De Groot, K., In vitro calcium phosphate formation on a natural composite material, bamboo (1997) Biomaterials, 18, pp. 389-395
},
	month = {2005///},
	pages = {31 - 39},
	abstract = {The proliferation of cultured human bone marrow stromal cells (HBMSC) on regenerated cellulose hydrogels was assessed. Regenerated cellulose hydrogels showed good rates of HBMSC proliferation, the cells exhibiting a flattened morphology, and after 22 days in culture, the cells had homogeneously colonized the surface of the materials. Moreover, since the early days in culture, between the surface of the materials and attached cells a continuous granulated hydroxyapatite layer was formed. It has been previously demonstrated in vitro, but without cells, that these materials did not mineralize. Hence, it seems that HBMSC promoted the mineralization of the surface.},
	keywords = {article, bone marrow cell, Bone Marrow Cells, bone mineralization, Calcification, Physiologic, Calcium phosphates, Cell culture, cell proliferation, cell regeneration, Cells, Cultured, Cellulose, hematopoietic stem cell, human, Human bone marrow stromal cells, human cell, Humans, hydrogel, Hydrogels, hydroxyapatite, in vitro study, mineralization, Regenerated cellulose hydrogels, Regeneration, Spectroscopy, Fourier Transform Infrared, stroma cell, Stromal Cells, Time series analysis},
	isbn = {14732262 (ISSN)},
	url = {http://www.scopus.com/inward/record.url?eid=2-s2.0-28444434484\&partnerID=40\&md5=336e1872af4f9b4274cda0b46e091486},
	author = {Granja, P.L. and De J{\'e}so, B. and Bareille, R. and Rouais, F. and Baquey, C. and Barbosa, M.A.}
}
